Skip to Content

Elite Pharmaceuticals Inc ELTP

Morningstar Rating
$0.14 0.00 (2.88%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

ELTP is trading at a 513% premium.
Price
$0.14
Fair Value
$1.24
Uncertainty
Extreme
1-Star Price
$6.90
5-Star Price
$4.13
Economic Moat
Hvyp
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ELTP is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.14
Day Range
$0.140.14
52-Week Range
$0.030.21
Bid/Ask
$0.14 / $0.15
Market Cap
$145.54 Mil
Volume/Avg
253,804 / 794,285

Key Statistics

Price/Earnings (Normalized)
6.49
Price/Sales
3.08
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Elite Pharmaceuticals Inc is a pharmaceutical company. It is principally engaged in the development and manufacture of oral, controlled-release products, using proprietary know-how and technology. The company's operating segment includes Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA). It generates maximum revenue from the ANDA segment. The company focuses on developing pain management products; manufacturing a line of generic pharmaceutical products with approved Abbreviated New Drug Applications; developing additional generic pharmaceutical products; development of other products in its pipeline including the products with its partners; and commercialization of new products.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Core
Total Number of Employees
53

Valuation

Metric
ELTP
Price/Earnings (Normalized)
6.49
Price/Book Value
3.14
Price/Sales
3.08
Price/Cash Flow
17.12
Price/Earnings
ELTP

Financial Strength

Metric
ELTP
Quick Ratio
1.14
Current Ratio
1.94
Interest Coverage
−2.43
Quick Ratio
ELTP

Profitability

Metric
ELTP
Return on Assets (Normalized)
33.53%
Return on Equity (Normalized)
52.96%
Return on Invested Capital (Normalized)
43.93%
Return on Assets
ELTP
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ZTS
Zoetis Inc Class AHnbgnyjnQfqfh$79.4 Bil
MKKGY
Merck KGaA ADRGmhsyllrJcrpk$79.0 Bil
HLN
Haleon PLC ADRTvkfycqrRfhwb$38.5 Bil
VTRS
Viatris IncYtkppbdnFtk$13.1 Bil
RDY
Dr Reddy's Laboratories Ltd ADRSgdsvclsbTffcc$11.7 Bil
CTLT
Catalent IncKkxlrfzfQxkbcx$10.0 Bil
CURLF
Curaleaf Holdings IncLpdypmvpCsv$4.2 Bil
PRGO
Perrigo Co PLCYkkzfmfsTmmd$4.1 Bil
PBH
Prestige Consumer Healthcare IncXsxhcmwXvzvvlq$3.2 Bil
GTBIF
Green Thumb Industries IncDxrncnhnjPmpm$3.1 Bil

Sponsor Center